Last reviewed · How we verify
Soothe® Lubricant Eye Drops
Soothe® Lubricant Eye Drops provide ocular surface lubrication and protection by forming a protective film over the cornea and conjunctiva.
Soothe® Lubricant Eye Drops provide ocular surface lubrication and protection by forming a protective film over the cornea and conjunctiva. Used for Dry eye syndrome / dry eye disease, Ocular irritation and discomfort.
At a glance
| Generic name | Soothe® Lubricant Eye Drops |
|---|---|
| Also known as | Soothe lubricant eye drops will be administered as needed. |
| Sponsor | Bausch & Lomb Incorporated |
| Drug class | Lubricant eye drop |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The drops contain mineral oil and petrolatum as lubricating agents that coat the eye surface, reducing friction and providing moisture to relieve dry eye symptoms. This mechanical lubrication helps protect the corneal epithelium and maintains tear film stability, providing comfort and reducing irritation associated with dry eye disease.
Approved indications
- Dry eye syndrome / dry eye disease
- Ocular irritation and discomfort
Common side effects
- Blurred vision
- Eye irritation
- Mild stinging or burning
Key clinical trials
- Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease) (PHASE2)
- Efficacy of Ketorolac 0.4% in Prostaglandin Suppression (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Soothe® Lubricant Eye Drops CI brief — competitive landscape report
- Soothe® Lubricant Eye Drops updates RSS · CI watch RSS
- Bausch & Lomb Incorporated portfolio CI